Harnessing Cuproptosis resistance to advance cancer therapeutics
{{output}}
Cancer treatment remains in need of novel therapeutic strategies to improve patient outcomes. Cuproptosis, a recently identified form of immunogenic cell death, is recognized for its significant anticancer potential. However, most cuproptosis-based strategies ... ...